Recent Quarter Total Invested
$1.09 B
Recent Quarter Institutional Ownership Percentage
113.51%
Total Invested of Last Quarter
$1.42 B
Ownership Percentage of Last Quarter
110.94%
Tarsus Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 08/14/2024 | 3.41 M | $92.75 M | 4.28% | 9.67% |
| BLACKROCK INC. | 08/13/2024 | 3.27 M | $88.79 M | 23.15% | 9.25% |
| PARADIGM BIOCAPITAL ADVISORS LP | 08/14/2024 | 2.44 M | $66.19 M | -14.95% | 6.90% |
| TANG CAPITAL MANAGEMENT LLC | 08/14/2024 | 2.25 M | $61.29 M | 0.00% | 6.39% |
| COWEN AND COMPANY, LLC | 08/07/2024 | 2.20 M | $59.72 M | 3.53% | 6.22% |
| VANGUARD GROUP INC | 08/13/2024 | 1.99 M | $54.08 M | 8.93% | 5.64% |
| MORGAN STANLEY | 10/17/2024 | 1.88 M | $51.23 M | -21.44% | 5.34% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 08/15/2024 | 1.59 M | $43.15 M | -11.19% | 4.50% |
| JENNISON ASSOCIATES LLC | 08/05/2024 | 1.48 M | $40.22 M | 11.19% | 4.19% |
| PERCEPTIVE ADVISORS LLC | 08/16/2024 | 1.30 M | $35.24 M | 0.00% | 3.67% |
| ASSENAGON ASSET MANAGEMENT S.A. | 07/18/2024 | 1.06 M | $28.90 M | 100.00% | 3.01% |
| STATE STREET CORP | 08/14/2024 | 925,639 | $25.16 M | 29.08% | 2.62% |
| IKARIAN CAPITAL, LLC | 08/14/2024 | 800,277 | $21.75 M | 12.67% | 2.27% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 773,235 | $21.02 M | 22.80% | 2.19% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 08/13/2024 | 670,459 | $18.22 M | 210.46% | 1.90% |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 08/12/2024 | 627,578 | $17.06 M | 0.02% | 1.78% |
| ENSIGN PEAK ADVISORS, INC | 08/13/2024 | 594,325 | $16.15 M | -18.35% | 1.68% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 08/14/2024 | 590,000 | $16.04 M | 0.00% | 1.67% |
| VIVO CAPITAL, LLC | 08/14/2024 | 565,550 | $15.37 M | 0.00% | 1.60% |
| TCG CROSSOVER MANAGEMENT, LLC | 08/14/2024 | 556,317 | $15.12 M | -29.92% | 1.58% |
| TFG ASSET MANAGEMENT GP LTD | 08/14/2024 | 500,000 | $13.59 M | 11.11% | 1.42% |
| CORMORANT ASSET MANAGEMENT, LP | 08/14/2024 | 500,000 | $13.59 M | -76.63% | 1.42% |
| LORD, ABBETT & CO. LLC | 10/07/2024 | 463,240 | $12.59 M | 463.37% | 1.31% |
| MACQUARIE GROUP LTD | 08/09/2024 | 454,991 | $12.37 M | 203.33% | 1.29% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2024 | 434,342 | $11.81 M | 193.82% | 1.23% |
| JEFFERIES FINANCIAL GROUP INC. | 08/13/2024 | 420,758 | $11.44 M | 55.40% | 1.19% |
| DIMENSIONAL FUND ADVISORS LP | 08/09/2024 | 406,899 | $11.06 M | -4.22% | 1.15% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 08/14/2024 | 400,000 | $10.87 M | 100.00% | 1.13% |
| INVESCO LTD. | 08/13/2024 | 391,563 | $10.64 M | 75.14% | 1.11% |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 09/20/2024 | 389,600 | $10.59 M | -56.61% | 1.10% |
| J. GOLDMAN & CO LP | 08/14/2024 | 387,161 | $10.52 M | 137.02% | 1.10% |
| NUVEEN ASSET MANAGEMENT, LLC | 08/09/2024 | 385,085 | $10.47 M | 145.61% | 1.09% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 08/15/2024 | 364,463 | $9.91 M | 126.15% | 1.03% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 348,586 | $9.47 M | 1,259.33% | 0.99% |
| TWO SIGMA ADVISERS, LP | 08/14/2024 | 307,600 | $8.36 M | 316.24% | 0.87% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2024 | 291,275 | $7.92 M | -16.22% | 0.83% |
| D. E. SHAW & CO., INC. | 08/14/2024 | 269,793 | $7.33 M | 37.29% | 0.76% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 261,879 | $7.12 M | 17.97% | 0.74% |
| NORTHERN TRUST CORP | 08/14/2024 | 253,016 | $6.88 M | 2.36% | 0.72% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 246,500 | $6.70 M | 1,316.67% | 0.70% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 243,112 | $6.61 M | 5.93% | 0.69% |
| GHOST TREE CAPITAL, LLC | 08/14/2024 | 235,000 | $6.39 M | -21.67% | 0.67% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2024 | 226,879 | $6.17 M | 580.03% | 0.64% |
| BOONE CAPITAL MANAGEMENT LLC | 08/14/2024 | 216,047 | $5.87 M | -64.53% | 0.61% |
| CITADEL ADVISORS LLC | 08/14/2024 | 207,489 | $5.64 M | -5.38% | 0.59% |
| GOLDMAN SACHS GROUP INC | 08/13/2024 | 205,551 | $5.59 M | 0.89% | 0.58% |
| BOOTHBAY FUND MANAGEMENT, LLC | 08/14/2024 | 200,094 | $5.44 M | 14.01% | 0.57% |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 07/26/2024 | 181,066 | $4.92 M | -5.84% | 0.51% |
| SANDS CAPITAL VENTURES, LLC | 08/13/2024 | 170,000 | $4.62 M | 0.00% | 0.48% |
| CAPTION MANAGEMENT, LLC | 08/14/2024 | 160,000 | $4.35 M | 100.00% | 0.45% |
Tarsus Pharmaceuticals, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of TARS shares?
During the previous two years, 181 institutional investors and hedge funds held shares of Tarsus Pharmaceuticals, Inc.. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 3.76 M
RTW INVESTMENTS, LP: 3.41 M
Paradigm Biocapital Advisors LP: 2.44 M
TANG CAPITAL MANAGEMENT LLC: 2.25 M
MORGAN STANLEY: 2.21 M
COWEN AND COMPANY, LLC: 2.2 M
-
What percentage of Tarsus Pharmaceuticals, Inc. stock is owned by institutional investors?
113.51% of Tarsus Pharmaceuticals, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at TARS ?
Institutional investors have bought a total of 44.39 M shares in the last 24 months. This purchase volume represents approximately $2.14 B in transactions.